hrp0089p3-p197 | GH & IGFs P3 | ESPE2018
Charmandari Evangelia
, Michalakos Stefanos
, Sakellariou Dimitris
, Koledova Ekaterina
, Chrousos George
The Easypod Connect Observational Study (ECOS) was the first global study of easypod, currently the only electronic injection device for recombinant human growth hormone (r-hGH; Saizen®). ECOS reported accurate and robust real-time adherence data in a large cohort of patients. In this analysis, we assess the adherence of r-hGH administered via easypod in a cohort of Greek patients from ECOS (EMR200104-520, NCT01363674). Patients aged 218...